5th International conference on Cancer Prevention and Research

The COVID-19 pandemic disrupted global cancer prevention efforts, shifting priorities within public health interventions and oncology research. Reduced access to healthcare facilities and postponed cancer screening programs resulted in missed opportunities for early detection and risk reduction. Lifestyle-related risk factors such as physical inactivity, poor diet, and stress also increased during lockdowns, contributing to higher long-term cancer susceptibility. These challenges highlighted the urgent need for stronger preventive oncology strategies and sustainable community-based prevention models. 

Session Overview: 

 This session will focus on innovative approaches to strengthen cancer prevention programs through multidisciplinary strategies, emphasizing the role of public health interventions and oncology research in identifying and mitigating cancer risk factors. Topics will include behavioral modifications, preventive lifestyle interventions, policy frameworks, and the integration of early detection through routine cancer screening. Participants will explore how global collaboration and technology can reinforce resilience in preventive oncology and long-term cancer control. 

The disruption caused by the COVID-19 pandemic led to significant delays in cancer screening programs worldwide, resulting in reduced rates of early detection and delayed diagnoses. Interruptions in routine check-ups, imaging services, and biopsy procedures affected the timely identification of precancerous conditions and early-stage tumors. These challenges underscored the importance of resilient screening infrastructures and the integration of digital and remote diagnostic technologies in oncology research and preventive oncology. 

Session Overview: 

This session will examine advances in screening and early detection strategies, focusing on evidence-based screening guidelines, biomarkers, and imaging innovations. Discussions will highlight the importance of public health interventions to expand access to cancer prevention and screening programs globally. Participants will explore the impact of emerging technologies—such as AI-assisted diagnostics and molecular imaging—on improving detection accuracy and patient outcomes in preventive oncology. 

The COVID-19 era renewed global attention on the power of vaccination in public health and cancer prevention. Immunization programs targeting oncogenic viruses such as HPV and Hepatitis B were disrupted, impacting long-term cancer control efforts. However, new research in immunoprevention and oncology research has advanced understanding of immune responses in cancer prevention and early detection, strengthening preventive healthcare frameworks. 

Session Overview: 

This session will explore progress in vaccination and immunoprevention, emphasizing their roles in preventive oncology and global cancer control. Topics include viral oncology vaccines, immune-modulating agents, and novel cancer-preventive immunotherapies. Discussions will also cover challenges in vaccine accessibility, policy-driven public health interventions, and future trends in combining immunization strategies with early detection and cancer screening initiatives for comprehensive prevention. 

The interplay between environmental exposure and occupational risks continues to shape global cancer prevention efforts. The COVID-19 pandemic disrupted surveillance programs and occupational safety research, delaying studies on carcinogen exposure, pollution, and lifestyle-associated risks. These challenges reinforced the critical role of public health interventions in reducing preventable cancer burdens through environmental monitoring and workplace safety policies.

Session Overview: 

This session will explore environmental and occupational determinants of cancer, emphasizing air pollution, radiation, industrial chemicals, and lifestyle factors as key contributors to cancer epidemiology and prevention. Experts will discuss preventive strategies, regulatory policies, and innovations in oncology research aimed at minimizing exposure risks. Emphasis will also be placed on integrating environmental health data into preventive oncology frameworks to improve population-level outcomes.

The growing interest in integrative and complementary medicine has expanded the landscape of preventive oncology and cancer research. During the pandemic, limitations in clinical access led patients to explore alternative therapies, such as herbal medicine, mindfulness, and nutritional interventions, underscoring the importance of scientific evaluation of these complementary approaches for cancer prevention and public health benefit. 

Session Overview: 

 This session will highlight complementary and emerging approaches in cancer prevention and treatment, including lifestyle modification, nutraceuticals, mind–body therapies, and non-invasive modalities. Discussions will focus on the role of evidence-based complementary medicine in oncology research, integration into clinical practice, and how emerging techniques such as nanomedicine and AI-driven diagnostics enhance cancer screening and therapeutic precision. 

Advancements in genetic research have transformed preventive oncology, allowing clinicians to predict and mitigate individual cancer risks. The pandemic slowed progress in genetic testing accessibility, but it also accelerated the use of tele-genetics and data-driven risk modeling, enabling more personalized cancer prevention approaches rooted in molecular oncology and population genomics. 

Session Overview: 

This session will explore how genetics and personalized medicine are revolutionizing cancer prevention. Topics include hereditary cancer syndromes, genomic screening, polygenic risk assessment, and gene–environment interactions. Participants will examine innovative oncology research integrating genomics with public health intervention strategies to enhance targeted prevention, early detection, and patient-specific therapeutic planning in preventive oncology. 

The COVID-19 pandemic significantly impacted cancer biology and genetics research, disrupting laboratory work and delaying discoveries in tumor mechanisms and mutation profiling. Despite these setbacks, new models of oncology research have emerged, emphasizing computational analysis and bioinformatics to sustain progress in understanding genetic pathways critical for cancer prevention and early detection. 

Session Overview: 

This session delves into cellular mechanisms, tumor progression, and genetic alterations driving cancer development. Subtopics include cancer genomics, epigenetic regulation, cell signaling, and DNA repair mechanisms. The discussion will focus on how advancements in molecular oncology and preventive oncology support the identification of biomarkers and therapeutic targets that enable precision prevention and improve clinical outcomes. 

The pandemic highlighted the immune system’s critical role in both infection defense and cancer prevention. Immunology research has driven innovations in vaccines, checkpoint inhibitors, and immune surveillance studies that connect public health and oncology research. Understanding immune responses to tumor cells continues to inspire new strategies in preventive oncology and immunoprevention. 

Session Overview: 

This session explores the mechanisms of immune regulation in cancer initiation, progression, and control. Topics include tumor immunology, immune evasion, immunotherapy development, and cancer vaccines. Experts will discuss breakthroughs in cancer immunology that integrate cancer prevention and early detection frameworks, advancing both therapeutic and preventive interventions to strengthen global cancer control strategies. 

Molecular oncology bridges cancer research and preventive oncology by decoding molecular and genetic alterations underlying tumor development. The pandemic accelerated the adoption of computational and molecular modeling tools, enabling deeper insights into cancer pathways and identifying novel biomarkers essential for early detection and targeted cancer prevention. 

Session Overview: 

This session will examine molecular mechanisms of carcinogenesis, signaling pathways, and drug resistance. Subtopics include precision oncology, gene expression profiling, and molecular diagnostics. The session emphasizes how oncology research integrates molecular data with public health interventions to develop predictive models and personalized cancer prevention approaches for improved screening and treatment outcomes. 

The pandemic posed unique challenges for hematologic malignancy management, with disruptions in diagnostics and treatment pathways. Despite this, advancements in hematology and oncology research have deepened understanding of blood-based biomarkers, stem cell dynamics, and immune-related mechanisms vital for cancer prevention and early detection.

Session Overview: 

 This session explores hematologic aspects of cancer, including leukemia, lymphoma, and myeloma research. Discussions will focus on blood cell genetics, immunohematology, and novel therapeutics. Experts will highlight innovations in preventive oncology, liquid biopsy technologies, and public health interventions that enhance diagnosis, monitoring, and personalized care in hematologic cancers. 

The COVID-19 pandemic disrupted diagnostic and therapeutic services worldwide, delaying cancer screening, early detection, and timely interventions. This emphasized the importance of robust healthcare systems and innovative strategies in oncology research to maintain effective cancer prevention and therapeutic care. 

Session Overview: 

This session focuses on advances in cancer diagnosis and treatment, including molecular diagnostics, imaging, and targeted therapies. Participants will explore integrating oncology research into preventive oncology, optimizing cancer screening programs, and designing interventions that improve patient outcomes. Emphasis will be placed on public health interventions to ensure broad access to diagnostic and therapeutic innovations. 

Pandemic-related restrictions prompted innovation in oncology research, accelerating digital trials and remote collaborations. Despite challenges, these developments advanced strategies in cancer prevention, early detection, and preventive oncology, reinforcing the need for agile and collaborative research models. 

Session Overview: 

This session highlights cutting-edge innovations in oncology research and preventive oncology, including translational studies, AI-assisted analytics, and novel clinical trial designs. Experts will discuss global collaboration, emerging technologies for cancer screening, and strategies to enhance cancer prevention outcomes, integrating findings into sustainable public health interventions worldwide. 

COVID-19 underscored the importance of advanced oncology research methods to sustain cancer prevention and early detection efforts. High-throughput sequencing, multi-omics analysis, and computational modeling became critical tools in overcoming laboratory disruptions, ensuring continuity in preventive oncology research. 

Session Overview: 

This session explores innovative methods in cancer research, including genomics, proteomics, AI-assisted predictive models, and liquid biopsy technologies. Discussions will focus on improving cancer screening, early detection, and preventive oncology, highlighting strategies to integrate technological advancements into public health interventions and evidence-based practice 

Pandemic-related disruptions affected cancer surveillance and population-level data collection, impacting global cancer prevention strategies and public health interventions. Despite challenges, research on risk factors, lifestyle determinants, and screening program effectiveness remained crucial for guiding preventive oncology initiatives and improving early detection outcomes.

Session Overview: 

This session examines trends in cancer epidemiology, population-level risk assessment, and evidence-based cancer prevention strategies. Topics include evaluation of screening programs, lifestyle interventions, policy-driven public health interventions, and integration of oncology research data to enhance preventive oncology measures. Participants will explore methods to optimize population-wide early detection and screening practices. 

The COVID-19 pandemic accelerated technological adoption, telehealth, and data-driven approaches in preventive oncology and oncology research. Emerging tools are shaping the future of cancer prevention, early detection, and cancer screening, driving personalized medicine and global public health interventions. 

Session Overview: 

 This session will focus on forward-looking trends in cancer prevention and oncology research, including precision medicine, AI and predictive analytics, next-generation biomarkers, and innovative screening strategies. Participants will explore global collaboration, integration of digital technologies, and development of resilient preventive oncology programs to anticipate future challenges and enhance early detection worldwide. 

The pandemic disrupted pediatric cancer care and cancer screening, affecting early diagnosis and intervention. Despite these challenges, oncology research has continued to explore tailored preventive oncology strategies for children, emphasizing genetic risk, immunoprevention, and innovative therapies to optimize cancer prevention and outcomes in pediatric populations. 

Session Overview: 

This session examines pediatric cancer epidemiology, risk factors, and preventive strategies, highlighting early detection, screening programs, and genetic counseling for children. Discussions will focus on emerging therapies, integrative preventive oncology, and public health interventions designed to improve outcomes and reduce pediatric cancer incidence, supported by the latest oncology research and clinical innovations.